TREA

97318817 - ORSHINA

Follow

Information

  • Trademark
  • 97318817
  • Serial Number
    97318817
  • Registration Number
    7342346
  • Filing Date
    March 18, 2022
    2 years ago
  • Registration Date
    April 02, 2024
    2 months ago
  • Transaction Date
    April 02, 2024
    2 months ago
  • Status Date
    April 02, 2024
    2 months ago
  • Published for Opposition Date
    January 16, 2024
    5 months ago
  • Location Date
    April 02, 2024
    2 months ago
Information
Mark Drawing Code
4000
Mark Identification
ORSHINA
Case File Statements
  • GS0051: Pharmaceuticals, in particular pharmaceuticals for treating fibrosis, pharmaceuticals for treating lung diseases, pharmaceuticals for treating inflammatory disorders, pharmaceuticals for treating scars and scar formation, pharmaceuticals for promoting tissue repair and/or tissue regeneration, pharmaceuticals for wound healing, wherein all aforementioned pharmaceuticals include small chemical molecules, peptides, proteins, nucleic acids, cellular products and gene therapy products; Diagnostic reagents, for medical and veterinary purposes
  • GS0011: Chemicals for use in industry and science, in particular reagents for labelling of biomolecules, reagents for tagging of biomolecules; reagents for non-medical purposes for visualization or detection of biomolecules; reagents for non-medical purposes for tagging of chemical entities or chemical molecules; reagents for non-medical purposes for generation of molecular constructs, transfection reagents, reagents for gene editing; reagents for non-medical purposes for investigations in relation to tissue disorders; reagents for non-medical purposes for investigations in relation to fibrosis; reagents for non-medical purposes for investigations in relation to inflammatory disorders; diagnostic reagents, not for medical or veterinary purposes; chemical reagent mixtures in kit form, other than for medical or veterinary use; Kits comprising reagents for use in scientific research, in particular kits for labelling of biomolecules; kits for non-medical purposes for tagging of biomolecules comprising reagents for tagging of biomolecules; kits for non-medical purposes for visualization or detection of biomolecules comprising reagents for visualization or detection of biomolecules; kits for non-medical purposes for generation of molecular constructs comprising reagents for generation of molecular constructs; transfection kits comprising reagents for transfection of cells; kits for non-medical purposes for gene editing comprising reagents for gene editing; kits for non-medical purposes for investigations in relation to tissue disorders comprising reagents for investigations in relation to tissue disorders; kits for non-medical purposes for investigations in relation to fibrosis comprising reagents for investigations of fibrosis; kits for non-medical purposes for investigations in relation to inflammatory disorders comprising reagents for investigations of inflammatory disorders; diagnostic kits comprising diagnostic reagents for scientific or research use not for medical and veterinary purposes
  • GS0441: Diagnosis and treatment of fibrosis, lung diseases, or scars or scar formation; Diagnosis and healing of wound; Diagnosis and healing being medical services of wounds; Medical treatment being tissue repair and/or tissue regeneration for treatment of inflammatory conditions; Treatment prediction and diagnostics in the field of medicine and veterinary medicine
  • GS0421: Scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields; Biochemical and pharmaceutical laboratory services, in particular in the field of discovery and development of drugs for treating fibrosis, lung diseases, or scars, drugs for preventing scar formation or drugs for wound healing, in the field of discovery of drugs for promoting tissue repair and/or tissue regeneration; Chemical and biochemical analysis of active ingredients in the field of drugs for treating fibrosis, lung diseases, or scars, or in the field of drugs for preventing scar formation or drugs for wound healing, or in the field of drugs for promoting tissue repair and/or tissue regeneration; Scientific research consultancy, in particular with respect to drug discovery methodologies and systems for drug discovery and with respect to drug development methodologies and systems for drug development
Case File Event Statements
  • 4/2/2024 - 2 months ago
    18 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 4/2/2024 - 2 months ago
    17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/16/2024 - 5 months ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/16/2024 - 5 months ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/27/2023 - 6 months ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/8/2023 - 6 months ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/1/2023 - 6 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/1/2023 - 6 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/1/2023 - 6 months ago
    10 - ASSIGNED TO LIE Type: ALIE
  • 6/28/2023 - 12 months ago
    9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/29/2023 - a year ago
    8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 3/29/2023 - a year ago
    7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 1/6/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/6/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/6/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/30/2022 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/23/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/22/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP